Bibliography
- CHOO QL, KUO G, WEINER AJ, OVERBY LR, BRADLEY DW, HOUGHTON M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis ge-nome. Science (1989) 244:359–362.
- HOOFNAGLE JH, DI BISCEGLIE AM: Drug therapy: the treatment of chronic viral hepatitis. New Engl. J. Med. (1997) 336(5) 347–356.
- HIJIKATA M, MIZUSHIMA H, AKAGI T et al. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. (1993) 67(8):4667–4675.
- GRAKOUI A, MCCOURT DW, WYCHOWSKI C, FEIN-STONE, SM, RICE CM: A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. USA (1993) 90(22) :10583–10587.
- KIM JL, MORGENSTERN KA, LIN C et al.: Crystal structure of the hepatitis C virus NS3 protease domain com-plexed with a synthetic NS4A cofactor peptide. Cell (196) 87(2):343–355.
- STEINKUHLER C, TOMEI L, DE FRANCESCO R: In vitro ac-tivity of hepatitis C virus protease NS3 purified from recombinant baculovirus-infected SF9 cells. J. Biol. Chem. (1996) 271(10:6367–6373.
- SMELLIE A, TEIG SL, TOWBIN P: Poling: promoting con-formational variation. J. Comp. Chem. (1995) 16 (2) :171–187.
- SMELLIE A, KAHN S, TEIG SL: Analysis of conforma-tional coverage. 2. Application of conformational models. J. Chem. Inf. Comp. Sci. (1995) 35(2):295–304.
- CHUM, MIERZWA R, TRUUMEES I et al. : Structure of Sch 68631: a new hepatitis C virus proteinase inhibitor from Streptomyces sp. Tett. Lett. (1996) 37 (40) 7229–7232.
- LLINAS-BRUNET M, BAILEY M, FAZAL G et al: Peptide-based inhibitors of the hepatitis C virus serine prote-ase. BioOrg. Med. Chem. Lett. (1998) 8(13):1713–1718.